Trials / Completed
CompletedNCT00171457
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Investigate the role of tegaserod in modulating gastric sensitivity to mechanical distention of the stomach
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegaserod |
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-09-01
- First posted
- 2005-09-15
- Last updated
- 2007-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00171457. Inclusion in this directory is not an endorsement.